Clinical Trial

Cognitive Level Enhancement Through Vision Exams and Refraction

Study acronym: CLEVER
Recruiting
View on ClinicalTrials.gov →
Summary
The investigators aim to conduct a mixed-method study in which a randomised controlled trial (RCT) and a descriptive qualitative study will be conducted. The RCT aims to determine whether free near and distance glasses provided to residents in Hyderabad, India, aged ≥ 60 years, with under- or un- corrected refractive error and normal baseline hearing and cognition (HMSE \> 18), can improve quality of life, reduce falls, reduce depression, improve social interaction and physical activity cost-effectively over 36 months. The primary qualitative research aim is to a) contextualize the RCT with information on the milieu and culture in which the trial will be conducted; b) provide data on the lived experiences of older adults with reduced vision in the study area, and c) conduct a process evaluation of the trial. The primary outcome measure is the three-year change in cognition measured by LASI- DAD (Longitudinal Aging Study in India(LASI)- Diagnostic Assessment of Dementia(DAD) global cognitive score. Secondary Outcome Measures: Three year change in Quality of Life score measured by WHO QOL-BREF; Visual functioning from the RASCH-scaled version of INDVFQ(Indian Visual Functioning(INDVFQ);self-reported physical activity score measured using IPAQ questionnaire; PHQ9 score; domain specific cognitive score (orientation, executive function, language/fluency, memory) measured by HMSE; Total cost of care including direct and indirect costs; Quality adjusted life years; Incremental Cost Effectiveness Ratio; Number of falls measured by Quick Screen score over the three years; Social network density at 3 years (SNI 1-3 represents a "limited" social network, 4-5 is a "medium" social network, and SNI ≥6 is a "diverse" social network) measured by the SNI score; An additional secondary outcome will be LASI-DAD global cognitive score analysed by excluding any tests determined pre-hoc to depend on visual acuity.
Protocol Amendment History 15 amendments
This ClinicalTrials.gov record has been amended 15 times since 2022-07-11; most recent amendment 2026-03-04.
Status change: Not Yet Recruiting → Recruiting 2024-02-16
Trial Details
NCT Number NCT05458323
Lead Sponsor Queen's University, Belfast
Collaborators: L.V. Prasad Eye Institute, National Institute of Mental Health and Neuro Sciences, India, The George Institute, Johns Hopkins University, University of Michigan, Clearly, Belfast Health and Social Care Trust
Conditions Refractive Errors
Enrollment 820 participants
Start Date 2024-01-18
Primary Completion 2027-11-30 (estimated)
Study Completion 2028-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-03-06